Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

Libtayo was the sixth PD-L/PD-L1 inhibitor to reach the market, starting out as a therapy for another skin cancer called cutaneous squamous cell carcinoma (CSCC), and the rarity of that disease ...

According to BioNTech, the immunotherapy is Sanofi and Regeneron’s Libtayo (cemiplimab ... NSCLC, cutaneous squamous cell carcinoma, and others. Each of these potential combination treatments ...

Risk factors for secondary skin cancer after blood or marrow transplant include those who had treatment with a monoclonal ...

A new pilot cohort study linked immune checkpoint inhibitors with a reduction in actinic keratoses in patients undergoing ...

The main risk factors for tonsil cancer are smoking, drinking alcohol and infection with the human papilloma virus (HPV). Most tonsil cancers are a type called squamous cell carcinoma. A small number ...

National Cancer Institute, Bethesda, Maryland, USA Background: Oesophageal squamous cell carcinoma (OSCC) has a very poor prognosis, which is largely due to late diagnosis. Successful early detection ...

Skin cancer often causes itching. Itching is more common with basal cell carcinoma and squamous cell carcinoma. Itching is less common with melanoma but may still be a symptom. Liver, Bile Duct, ...